September 2026

Rural practices struggle | BP drug recalled | An early look at IVL tech | New GLP-1 data | Managing noncardiac surgeries ()
The top hospitals for pediatric heart surgery | A breakthrough procedure | FDA takes on surgical robots | A decade of success ()
Cardiologist compensation climbs | FDA clears AI for valve disease | Draft guidance takes on surgical robots | Vascular dementia ()
Artificial sweetener linked to multiple risks | J&J sells heart tech to startup | FDA impressed by new-look stroke device ()
FDA confirms recall for Impella controllers | New funding for AI | Persistent MR & TAVR | Care at for-profit hospitals ()
FDA shares Impella warning | Will AI replace cardiologists? | Stress & heart damage | Doctor impaled | New semaglutide data ()
The top children’s heart hospitals | AHA's global efforts | Intravascular imaging & PCI | Closing outcome gaps ()
Will AI replace cardiologists? | Semaglutide protects the heart, but experts are stumped | HF care in the US | HRT & blood clots ()
FDA's Impella warning | Improving care worldwide | AI evaluates risk | Battle of the ATTR-CM drugs | Medtech veteran's new gig ()
Coverage changes for heart failure & TAVR | The push to make medical training more affordable | BP drug recalled | Stroke rehab ()
First procedure of its kind performed in US | FDA clears heart preservation tech | Cardiologist impaled by branch | TAVR timing ()
Cardiologists named to USPSTF | The top children’s heart hospitals | A decade of success | Record-breaking attendance ()
FDA approves new drug-eluting balloon | AI's role in EP | Screening for valve dysfunction after TAVR | AHA to honor surgeon ()
AEDs recalled | Soccer player sues her cardiologist | FDA approves small leadless pacemaker | J&J sells heart tech to startup ()
Scientific statement takes on CKD in women | The growing roles of 3D printing & VR | Chronic stress & the heart | Unlocking data ()
BP drug recalled | FDA approves new leadless pacemaker | Early reactions to TAVR changes | Cardiologists accused of fraud ()
New data on BP changes in women | Intravascular imaging & PCI | Catheters linked to injury risk | Stroke rehab recommendations ()
Practice-changing research | Cardiologists named to USPSTF | Soccer player sues her cardiologist | Biotech company secures grant ()
New heart failure guidelines include major updates | Screening program delivers | A big CMS announcement | Metformin falls short ()
Johnson & Johnson sells off LAA closure tech | The value of intravascular imaging | How whole-grain foods protect the heart ()
The top children’s heart hospitals | CMS announces ACCESS update | FDA impressed by stroke device | Good news for Abbott ()
Previewing TCT 2026 | CMS announces major TAVR updates | A breakthrough in tricuspid valve care | Transfemoral TMVR ()
Building a CCTA program | 10 years of success | A new look at high blood pressure in women | TCT 2026 | AI for Lp(a) screening ()
How to integrate advanced AI models | Good news for the ‘Queen of Hearts’ | Digital twins impress | FDA clears imaging software ()
Early reactions to TAVR changes | Closing outcome gaps | BP drug recalled | Docs accused of fraud | New bill could help trainees ()
Top 10 most popular cardiology video interviews this past month ()
Major changes to TAVR policies | New stress testing guidelines | AEDs recalled | Heart drug falls short | Much more ()
CMS makes major TAVR changes | Stryker recalls AEDs | A new CVD risk factor | Cardiac PET Alliance launches | FDA OKs TAVR tech ()
Breaking News: CMS finalizes sweeping TAVR changes ()
SCAI pushes back on unpopular policy | Cardiologist disciplined | Procedure kits recalled | The power of quality improvement ()
New stress testing recommendations | Heart failure & TAVR | Tracking hormonal changes in women | FDA clears imaging platform ()
Cardiologist compensation still rising | Medtronic invests in Pi-Cardia | One health system sues another | $31M for stroke tech ()
FDA approves dual-energy ablation catheter | Hub-and-spoke models & CCTA | Surgeon makes history | New heart drug falls short ()
FDA authorizes new AI for heart attacks | ESC's record-breaking attendance | Medtronic secures labeling update | Nurses & HF ()
How to integrate AI into existing workflows | New CCTA recommendations | GE HealthCare announces 3 new ultrasound systems ()
Imaging catheters removed from market | AFib ablation fails to improve QOL | New heart failure guidelines | TAVR & PCI ()
Artificial sweetener found in gum, toothpaste linked to major risks | BP drug recalled | 8 in 10 young adults have CKM syndrome ()
Heart devices sending delayed alerts | FDA clears imaging software | Stroke recommendations | Sugar substitute linked to risks ()
TAVR Highlights: Medtronic's big investment | A new anchoring technique | Large aortic annuli | Predicting mortality risk ()
New CCTA recommendations | Health equity is now a business imperative | Edwards valve makes US debut | Redefining heart attack ()
Medtronic invests in Pi-Cardia—is a buyout next? | Sex-specific thresholds for CCTA | Key updates from ESC Congress 2026 ()
August's Top Stories: Blood thinner recalled | Early signs of inflammation | The best US hospitals | Cardiologist disciplined ()
ESC Congress 2026: AFib ablation & quality of life | A potential treatment for nonobstructive HCM | TAVR & PCI | Much more! ()